---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-239193"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2024-10-18T23:59:59+00:00"
generated_at: "2026-05-30T12:54:28.006311+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# David Joyner named CVS Health CEO replacing Karen Lynch; preliminary Q3 EPS guide weak

## Summary
- David Joyner appointed President and CEO effective Oct. 17, 2024, succeeding Karen Lynch who resigned.
- Roger Farah elevated to Executive Chairman of the Board.
- Preliminary Q3 2024 GAAP diluted EPS $0.03-$0.08; adjusted EPS $1.05-$1.10.
- Results include $1.1B premium deficiency reserve charge and $1.2B restructuring charge.
- MBR expected ~95.2%; prior guidance withdrawn due to elevated medical cost trends.

## SEC filing metadata
- accession: 0001193125-24-239193
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2024-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/0001193125-24-239193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/d837701d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-239193
- JSON: https://secwatch.observer/filing/0001193125-24-239193.json
- Plain text: https://secwatch.observer/filing/0001193125-24-239193.txt

## Key facts
- Executive change
  Karen S. Lynch resigned as President and Chief Executive Officer at CVS HEALTH Corp.
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: Karen S. Lynch ceased to serve as President and Chief Executive Officer of the Company and resigned as a member of the Board on the same day.
  evidence_url: https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/0001193125-24-239193-index.htm
- Executive change
  Roger N. Farah was appointed as Executive Chairman of the Board at CVS HEALTH Corp.
  - Action: appointed
  - Role: Executive Chairman of the Board
  source text: Effective October 17, 2024, the Board has also appointed current Chairman Roger N. Farah as Executive Chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/0001193125-24-239193-index.htm
- Executive change
  J. David Joyner was appointed as President and Chief Executive Officer at CVS HEALTH Corp.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: the Board of Directors (the “ Board ”) of the Company appointed J. David Joyner as President and Chief Executive Officer of the Company, effective as of October 17, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/64803/000119312524239193/0001193125-24-239193-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.